Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Adipose-derived Mesenchymal Stem Cells (MSC) for Acute Kidney Injury After Trauma or Burn

NCT06654193 is registered in ClinicalTrials.gov with Hope Biosciences LLC as lead sponsor.

NCT NCT06654193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06654193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Adipose-derived Mesenchymal Stem Cells (MSC) for Acute Kidney Injury After Trauma or Burn
Lead sponsor
Hope Biosciences LLC
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 1, 2026
Completion date
January 1, 2028
Enrollment
70 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury